Comparing Two Methods to Stop Vomiting of Blood Using the Endoscope
Control of Acute Variceal Bleeding Using the Multi-shooter Band Ligator Compared to Injection Sclerotherapy.
1 other identifier
interventional
200
1 country
1
Brief Summary
Band ligation and injection sclerotherapy are two modalities of treatment that are applied using the endoscope. The purpose of this study is to determine which of two methods is better for controlling bleeding from the upper gut.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started May 2008
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 26, 2010
CompletedFirst Posted
Study publicly available on registry
May 27, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedDecember 4, 2014
December 1, 2014
3.3 years
May 26, 2010
December 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
control of hematemesis
Success for either techniques to be able to stop the bleeding promptly and maintain that for 72 hours
72 hours
Secondary Outcomes (1)
occurence of complications from the intervention
30 days
Study Arms (2)
band ligation group
ACTIVE COMPARATORthis group will have immediate control of the hematemesis by endoscopic band ligation.
sclerotherapy group
ACTIVE COMPARATORThis group will have immediate control of hematemesis by endoscopic sclerotherapy
Interventions
Endoscopy is performed to diagnose the cause of hematemesis and to control it using band ligation or sclerotherapy
Eligibility Criteria
You may qualify if:
- Active hematemesis
- esophageal varices
You may not qualify if:
- Hemodynamic unstability
- Hepatic coma or precoma
- Tense ascitis
- Coagulopathies
- concomitant gastric varices
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hematemesis unit, Alexandria Main University Hospital, Azarita
Alexandria, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yasser Hamza, A Prof
University of Alexandria
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
May 26, 2010
First Posted
May 27, 2010
Study Start
May 1, 2008
Primary Completion
September 1, 2011
Study Completion
July 1, 2012
Last Updated
December 4, 2014
Record last verified: 2014-12